Oncolysis by paramyxoviruses: preclinical and clinical studies

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy

Bericht von Prof. Dr. Schirrmacher im International Journal of Oncology zu den Erkenntnissen der Tumor-reaktiven T-Zell-Memory im Knochenmark

Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients

Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance

Immunotherapy for hepatocellular carcinoma

Sensitivity of Human Malignant Melanoma Cell Lines to Newcastle Disease Virus

Natural and therapy-induced immunosurveillance in breast cancer

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma